Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Frequently asked questions
What sector does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Protagenic Therapeutics (PTIX) current stock price?
As of the latest data, Protagenic Therapeutics stock price is $0.36, with a previous close of $0.36.
What is Protagenic Therapeutics (PTIX) current market capitalization?
Protagenic Therapeutics market cap is approximately 651.67 thousand.
What is Protagenic Therapeutics (PTIX) Earnings Per Share (EPS)?
The trailing EPS is -$13.13.
Does Protagenic Therapeutics (PTIX) pay dividends?
No. Protagenic Therapeutics does not pay a dividend.
What is Protagenic Therapeutics (PTIX) beta (volatility) score?
Protagenic Therapeutics has a beta of 0.377, indicating lower volatility than the overall market.